News

Barchart on MSN9h
As Palantir Makes a Big Bet on AI-Powered Weather, Is PLTR Stock a Buy, Sell, or Hold?
Palantir (PLTR) recently announced that it is partnering with weather-intelligence pioneer Tomorrow.io to turn global ...
1PLTR : Palantir Bull Sees 562% Upside: '$500 Is The Lowest The Stock Can Be In...
A long-time Palantir Technologies bull, Tom Nash, is doubling down on the stock following its 434% rally over the past 12 months.
Why Palantir Stock Skyrocketed 80.3% in the First Half of 2025 -- and Has Kept Rising
Palantir (NASDAQ: PLTR) stock saw a massive rally across the first half of 2025's trading. The tech company's share price ...
This former Palantir bear changed his tune on the stock. Here’s why.
A Mizuho analyst isn’t ready to turn bullish just yet, but he abandoned his bearish call while writing that the company’s “recent execution and momentum is stunning.” ...
Palantir Stock Is Gaining Again On Monday: What's Going On?
Shares of Palantir Technologies are trading higher Monday. The data analytics firm's stock is up after positive news from ...
Prediction: This Artificial Intelligence (AI) Stock Will Be Worth $1 Trillion in 5 Years
Palantir has jumped 5x in the past year, and it still has room for more upside despite an expensive valuation. The rapid ...
Explore more
Knightscope stock rises after signing agreement with Palantir
Investing.com -- Knightscope Inc (NASDAQ: KSCP) stock gained over 6% on Thursday after the autonomous security robot ...
24/7 Wall St. on MSN1d
Stock Market Live July 16: Surprisingly Mild Inflation Report Drives S&P 500 (VOO) Higher
Live Updates Live Coverage Updates appear automatically as they are published. Oil Cools Off 9:38 am Citigroup downgraded a ...
Thinking of Buying Palantir Stock? Here Are 2 Red Flags to Watch.
With a strong brand and a mover advantage, the company seems positioned to benefit from the broader AI wave. However, beneath ...
Palantir Technologies (PLTR) Advances Federal And Clinical AI Solutions With New Collaborations
Palantir Technologies (PLTR) has recently forged partnerships with Knightscope Inc. for entry into the U.S. federal marketplace and with Velocity Clinical Research to enhance clinical trial efficiency ...